DAY ONE JP Morgan Presentation.pdf

1、Day One BiopharmaceuticalsTargeted therapies for people of all agesJanuary 202543rd Annual J.P.Morgan Healthcare ConferenceForward looking statements2This presentation and the accompanying oral commentary contain forward-looking statements that are based on our managements beliefs and assumptions an

2、d on information currently available to our management.Forward-looking statements are inherently subject to risks and uncertainties,some of which cannot be predicted or quantified.In some cases,you can identify forward-looking statements by terminology such as“may,”“will,”“should,”“could,”“expect,”“

3、plan,”anticipate,”“believe,”“estimate,”“predict,”“intend,”“potential,”“would,”“continue,”“ongoing”or the negative of these terms or other comparable terminology.Forward-looking statements include all statements other than statements of historical fact contained in this presentation,including informa

4、tion concerning our future financial performance,including the sufficiency of our cash,cash equivalents and short-term investments to fund our operations,business plans and objectives,timing and success of our commercialization and marketing efforts,timing and success of our planned nonclinical and

5、clinical development activities,the results of any of our strategic collaborations,including the potential achievement of milestones and provision of royalty payments thereunder,efficacy and safety profiles of our products and product candidates,the ability of OJEMDA(tovorafenib)to treat pediatric l

6、ow-grade glioma(pLGG)or related indications,the potential therapeutic benefits and economic value of our products and product candidates,potential growth opportunities,competitive position,industry environment and potential market opportunities,our ability to protect intellectual property and the im